Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


Patel Samir Rashmikant Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A Patel Samir Rashmikant reports a 9.9% stake in Akari Therapeutics, PLC
02/14/2022 SC 13G/A Patel Samir Rashmikant reports a 6.2% stake in Akari Therapeutics, PLC
11/30/2021 4/A Patel Samir Rashmikant (Director) has filed a Form 4 on CytoDyn Inc.
Txns: Disposed/sold 225,000 options to buy @ $1.39, valued at $312.8k
Granted 112,500 options to buy @ $1.39, valued at $156.4k
Disposed/sold 225,000 options to buy @ $6.15, valued at $1.4M
Granted 225,000 options to buy @ $6.15, valued at $1.4M
Disposed/sold 12,329 options to buy @ $2.25, valued at $27.7k
Granted 12,329 options to buy @ $2.25, valued at $27.7k
11/29/2021 4 Patel Samir Rashmikant (Director) has filed a Form 4 on CytoDyn Inc.
Txns: Disposed/sold 225,000 options to buy @ $1.39, valued at $312.8k
Granted 93,750 options to buy @ $1.39, valued at $130.3k
Disposed/sold 225,000 options to buy @ $6.15, valued at $1.4M
Granted 225,000 options to buy @ $6.15, valued at $1.4M
Disposed/sold 12,329 options to buy @ $2.25, valued at $27.7k
Granted 12,329 options to buy @ $2.25, valued at $27.7k
10/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2021 SC 13G/A Patel Samir Rashmikant reports a 7.2% stake in Akari Therapeutics, PLC
06/26/2020 4 Patel Samir Rashmikant (Director) has filed a Form 4 on CytoDyn Inc.
Txns: Granted 225,000 options to buy @ $6.15, valued at $1.4M
04/22/2020 3/A Patel Samir Rashmikant (Director) has filed a Form 3/A on CytoDyn Inc.
04/22/2020 4 Patel Samir Rashmikant (Director) has filed a Form 4 on CytoDyn Inc.
Txns: Granted 12,329 options @ $2.25, valued at $27.7k
04/22/2020 3 Patel Samir Rashmikant (Director) has filed a Form 3 on CytoDyn Inc.
02/14/2020 SC 13G/A Patel Samir Rashmikant reports a 6.7% stake in Akari Therapeutics, PLC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy